By Brian Niemietz New York Daily News Sep 19, 2019
Purdue Pharma LP — the company that’s been called largely responsible for the country’s opioid problem — will only be able to pay the $10 billion settlement it agreed to at the start of of this week if it’s able to sell more OxyContin over the next seven years, according to Bloomberg.
On Sunday, Purdue filed a bankruptcy claim stating the pharmaceutical giant had settled a class action suit with 24 states that could cost up to $10 billion, though Bloomberg, citing three people familiar with the proposal, reported that only $4.4 billion of that deal involves cash.
"The remaining $5.6 billion depends on “optimistic assumptions of insurance payments and future sales of its highly addictive OxyContin painkiller over seven years,†Bloomberg claimed.
More:
https://www.nydailynews.com/news/national/ny-purdue-pharma-settlement-10-billion-oxycontin-opioid-20190919-4eqdqwwfmfhxlkpjqtna4vxrza-story.html
